We collaborate with local and overseas partner institutions in research and healthcare. Together with leading clinical advisors, we aim to propel Raya Regenerative to the forefront of stem cell therapy with their critical expertise and experience on the development of our clinical pipelines.
We uphold our belief in patients’ confidentiality and safety. We designed our proprietary quality assurance processes with high stringency and in line with current FDA and international standards. All cells and its derivatives are isolated under GMP environment and rigorously assessed for defined quality indicators.
Under the partnership with The FoReM, Raya Regenerative is US IRB-approved to conduct researches on human subjects
Currently, we are conducting research on stem cell / exosome therapies on Autism, Parkinson’s Disease, and Retinitis Pigmentosa
Parkinson’s Disease, and Retinitis Pigmentosa Our passion for research ensures that we provide treatments that are safe and backed by clinical studies.
We collaborate with local and overseas partner institutions in research and healthcare. Together with leading clinical advisors, we aim to propel Raya Regenerative to the forefront of stem cell therapy with their critical expertise and experience on the development of our clinical pipelines.
Our groundbreaking innovations are led by Dr. Quincy Raya (Philippines) from Harvard and Dr. Chadwick Prodromos (USA) from Princeton, both of whom bring over 60 years of expertise to the field. They have been at the forefront of stem cell research, pioneering several significant advancements in regenerative medicine.
Harvard
Princeton - Founder of The FoReM
Complete our brief screening application to find out if you are a candidate for our measenchymal stem cell based treatment protocol.
Trusted by over 1000+ patients worldwide and partnered with leading stem cell research organizations.